- Home
- PHAR vs DGICB Comparison
PHAR vs DGICB Comparison
Compare PHAR & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- DGICB
- Stock Information
- Founded
- PHAR 1988
- DGICB 1986
- Country
- PHAR Netherlands
- DGICB United States
- Employees
- PHAR N/A
- DGICB N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- DGICB Property-Casualty Insurers
- Sector
- PHAR Health Care
- DGICB Finance
- Exchange
- PHAR Nasdaq
- DGICB Nasdaq
- Market Cap
- PHAR 587.5M
- DGICB 605.9M
- IPO Year
- PHAR N/A
- DGICB N/A
- Fundamental
- Price
- PHAR N/A
- DGICB $16.62
- Analyst Decision
- PHAR Strong Buy
- DGICB
- Analyst Count
- PHAR 3
- DGICB 0
- Target Price
- PHAR $30.00
- DGICB N/A
- AVG Volume (30 Days)
- PHAR 4.6K
- DGICB 1.3K
- Earning Date
- PHAR 05-08-2025
- DGICB 04-24-2025
- Dividend Yield
- PHAR N/A
- DGICB 3.73%
- EPS Growth
- PHAR N/A
- DGICB 1026.10
- EPS
- PHAR N/A
- DGICB 1.50
- Revenue
- PHAR $297,200,000.00
- DGICB $989,605,050.00
- Revenue This Year
- PHAR $8.26
- DGICB $5.29
- Revenue Next Year
- PHAR $9.73
- DGICB $5.85
- P/E Ratio
- PHAR N/A
- DGICB $12.60
- Revenue Growth
- PHAR 21.15
- DGICB 6.71
- 52 Week Low
- PHAR $6.65
- DGICB $10.75
- 52 Week High
- PHAR $11.07
- DGICB $18.50
- Technical
- Relative Strength Index (RSI)
- PHAR 45.53
- DGICB 55.94
- Support Level
- PHAR $7.79
- DGICB $15.86
- Resistance Level
- PHAR $8.51
- DGICB $16.99
- Average True Range (ATR)
- PHAR 0.47
- DGICB 0.24
- MACD
- PHAR 0.01
- DGICB -0.08
- Stochastic Oscillator
- PHAR 49.08
- DGICB 56.72
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.